These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8090664)

  • 41. [Early efficacy of recombinant human erythropoietin in treatment of anemia].
    Huang S; Yang L; Huang M
    Hua Xi Yi Ke Da Xue Xue Bao; 1996 Sep; 27(3):317-9. PubMed ID: 9389072
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Erythropoietin therapy in chronic uremia: the impact of normalization of hematocrit.
    Murphy ST; Parfrey PS
    Curr Opin Nephrol Hypertens; 1999 Sep; 8(5):573-8. PubMed ID: 10541220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stable renal function and benign course in azotemic diabetics treated with erythropoietin for one year.
    Brown CD; Friedman EA
    Contrib Nephrol; 1991; 88():182-9; discussion 190-1. PubMed ID: 2040181
    [No Abstract]   [Full Text] [Related]  

  • 44. L-Carnitine effects on anemia in uremic rats treated with erythropoietin.
    Azzadin A; Wollny T; Pawlak R; Malyszko JS; Malyszko J; Myśliwiec M; Buczko W
    Nephron; 1999; 83(4):370-1. PubMed ID: 10575305
    [No Abstract]   [Full Text] [Related]  

  • 45. Recombinant human erythropoietin therapy. Part I: clinical issues.
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):1-34. PubMed ID: 2928605
    [No Abstract]   [Full Text] [Related]  

  • 46. Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis.
    Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Salvadeo A
    Nephron; 1992; 61(1):54-7. PubMed ID: 1528341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hemo-rheologic changes following treatment with human recombinant erythropoietin in chronic hemodialysis patients].
    Melappioni M; Giansanti R; Boemi M; Baldassari M; Baldini S; Pierangeli T; Radicioni R; Fumelli P; Panichi N
    Minerva Urol Nefrol; 1992; 44(2):155-9. PubMed ID: 1411865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of recombinant human erythropoietin on porphyrin metabolism in uremic patients on hemodialysis.
    Fontanellas A; Herrero JA; Coronel F; Santos JL; Morán MJ; Barrientos A; Enríquez de Salamanca R
    J Am Soc Nephrol; 1996 May; 7(5):774-9. PubMed ID: 8738813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular abnormalities in end stage renal failure: the effect of anaemia or uraemia?
    Morris KP; Skinner JR; Hunter S; Coulthard MG
    Arch Dis Child; 1994 Aug; 71(2):119-22. PubMed ID: 7944530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of renal anemia using human erythropoietin].
    Zehnder C; Blumberg A
    Dtsch Med Wochenschr; 1987 Jun; 112(23):938-9. PubMed ID: 3582205
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of renal anemia with recombinant erythropoietin. International workshop. Wolfenbüttle, November 22-24, 1987. Proceedings.
    Contrib Nephrol; 1988; 66():1-211. PubMed ID: 3391026
    [No Abstract]   [Full Text] [Related]  

  • 52. [Serum erythropoietin concentration before and after partial correction of renal anemia].
    Radtke HW; Erbes PM; Koch KM
    Verh Dtsch Ges Inn Med; 1978; (84):1279-81. PubMed ID: 741948
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of erythropoietin therapy on the red cell volume of uraemic and non-uraemic rats.
    Anagnostou A; Barone J; Kedo A; Fried W
    Br J Haematol; 1977 Sep; 37(1):85-91. PubMed ID: 588481
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful treatment of rHuEpo in uremic pregnancy.
    Rotolo U; Gugliotta G; Lampasona G; Cucinella G; Speciale P; Rinaldi A
    Clin Nephrol; 1994 May; 41(5):320. PubMed ID: 8050215
    [No Abstract]   [Full Text] [Related]  

  • 55. [Resistance to EPO. Hyperfunction of the parathyroid glands].
    Kokot F
    Przegl Lek; 1995; 52(3):86-7. PubMed ID: 7644680
    [No Abstract]   [Full Text] [Related]  

  • 56. Vitamin E alleviates the oxidative stress of erythropoietin in uremic children on hemodialysis.
    Németh I; Túri S; Haszon I; Bereczki C
    Pediatr Nephrol; 2000 Jan; 14(1):13-7. PubMed ID: 10654322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of recombinant human erythropoietin on growth hormone responses to growth hormone releasing hormone in uremic patients.
    Díez JJ; Iglesias P; Selgas R
    Clin Nephrol; 1994 Feb; 41(2):119. PubMed ID: 8004829
    [No Abstract]   [Full Text] [Related]  

  • 58. Histidine supplements in the treatment of uraemic anaemia.
    Giordano C; De Santo NG; Rinaldi S; Acone D; Esposito R; Gallo B
    Proc Eur Dial Transplant Assoc; 1973; 10(0):160-5. PubMed ID: 4802497
    [No Abstract]   [Full Text] [Related]  

  • 59. Recombinant human erythropoietin may correct erythropoietin-deficient hyporegenerative anaemia in children given cardiac transplantation.
    Locatelli F; Zecca M; Mamprin F; Gamba A; Giorgiani G; De Stefano P
    Br J Haematol; 1994 Nov; 88(3):623-5. PubMed ID: 7819078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of erythropoietin treatment on endocrine abnormalities in haemodialyzed patients.
    Kokot F; Wiecek A; Grzeszczak W; Klepacka J; Klin M; Lao M
    Contrib Nephrol; 1989; 76():257-70; discussion 270-2. PubMed ID: 2582782
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.